In a mouse model of orthotopic pancreatic cancer, anchoring of fibronectin extra domain B targeting peptide to abundant tumor-associated fibronectin in ECM promoted the retention of these nanosystems in the tumor stroma after intravenous injection. This evidence concerns the gene FN1 and pancreatic neoplasm.